A solid combo.

In murine models, oxaliplatin with immune checkpoint inhibition activates tumor macrophages to induce CAR-T cell recruitment, cracking the door for CAR-T cell use in solid tumors. | Srivastava, Cancer Cell 2020

Comments

Popular Posts